Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jeffrey V Groom"'
Autor:
Pamela T Wong, Pascale R Leroueil, Douglas M Smith, Susan Ciotti, Anna U Bielinska, Katarzyna W Janczak, Catherine H Mullen, Jeffrey V Groom, Erin M Taylor, Crystal Passmore, Paul E Makidon, Jessica J O'Konek, Andrzej Myc, Tarek Hamouda, James R Baker
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0126120 (2015)
Vaccine adjuvants have been reported to induce both mucosal and systemic immunity when applied to mucosal surfaces and this dual response appears important for protection against certain pathogens. Despite the potential advantages, however, no mucosa
Externí odkaz:
https://doaj.org/article/4084c3c916ea48baa41149fcafb14c47
Autor:
Paul E. Makidon, Luz P. Blanco, Jeffrey V. Groom, Igor M. Belyakov, Jeffrey J. Landers, Katarzyna W. Janczak, James R. Baker, Anna U. Bielinska
Publikováno v:
European Journal of Immunology. 42:2073-2086
While the nasal mucosa is a potentially useful site for human immunization, toxin-based nasal adjuvants are generally unsafe and less effective in humans. Safe mucosal adjuvants that activate protective immunity via mucosal administration are highly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf88f82404e4b4f1d04d15495f7754bd
https://doi.org/10.1002/eji.201142346
https://doi.org/10.1002/eji.201142346
Autor:
John J. LiPuma, James R. Baker, Anna U. Bielinska, Jessica A. Knowlton, Paul E. Makidon, Luz P. Blanco, Jeffrey V. Groom
Publikováno v:
Medical Microbiology and Immunology. 199:81-92
Burkholderia cepacia complex (Bcc) are opportunistic bacteria associated with life-threatening illness in persons with cystic fibrosis. Once Bcc colonization is established, these antimicrobial-resistant and biofilm-forming bacteria are difficult to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b29148daec8da5583c3ca2ba6482f005
https://doi.org/10.1007/s00430-009-0137-2
https://doi.org/10.1007/s00430-009-0137-2
Autor:
Paul E, Makidon, Igor M, Belyakov, Luz P, Blanco, Katarzyna W, Janczak, Jeffrey, Landers, Anna U, Bielinska, Jeffrey V, Groom, James R, Baker
Publikováno v:
European journal of immunology. 42(8)
While the nasal mucosa is a potentially useful site for human immunization, toxin-based nasal adjuvants are generally unsafe and less effective in humans. Safe mucosal adjuvants that activate protective immunity via mucosal administration are highly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4beffb99e2365838ed3ac48c92802475
https://pubmed.ncbi.nlm.nih.gov/22653620
https://pubmed.ncbi.nlm.nih.gov/22653620
Autor:
Andrzej Myc, Susan Ciotti, Katarzyna W. Janczak, Douglas M. Smith, Erin M. Taylor, Anna U. Bielinska, James R. Baker, Pamela T. Wong, Tarek Hamouda, Paul E. Makidon, Jeffrey V. Groom, Pascale R. Leroueil, Catherine H. Mullen, Jessica J. O’Konek, Crystal Passmore
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 5, p e0126120 (2015)
PLoS ONE, Vol 10, Iss 5, p e0126120 (2015)
Vaccine adjuvants have been reported to induce both mucosal and systemic immunity when applied to mucosal surfaces and this dual response appears important for protection against certain pathogens. Despite the potential advantages, however, no mucosa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75f9efb7cd83bfe0959a208984e7504
https://doi.org/10.1371/journal.pone.0126120
https://doi.org/10.1371/journal.pone.0126120